Cerenome CNSY
NASDAQ CNSY
$2.96 +0.02 (+0.68%)
As of: Sep 3, 2026 · 3:56 PM EDT

Cerenome (CNSY) Non-Current Deffered Revenue (2010 - 2023)

Analysis

Cerenome (CNSY) Non-Current Deffered Revenue (2010 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn -
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn - -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn -
10 Cerenome 20.42 Mn 11.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.92 Mn
Dec 31, 2022 1.64 Mn
Mar 31, 2019 142,000.00
Dec 31, 2018 167,000.00
Sep 30, 2018 187,000.00
Jun 30, 2018 93,000.00
Mar 31, 2018 105,000.00
Dec 31, 2017 107,000.00
Sep 30, 2017 120,000.00
Jun 30, 2017 136,000.00
Mar 31, 2017 17,000.00
Dec 31, 2016 17,000.00
Sep 30, 2016 41,000.00
Jun 30, 2016 111,000.00
Mar 31, 2016 189,000.00
Dec 31, 2015 269,000.00
Sep 30, 2015 348,000.00
Jun 30, 2015 419,000.00
Mar 31, 2015 507,000.00
Dec 31, 2014 558,000.00